What we do

Medicines that make a difference

Our mission is to make a meaningful difference to healthcare through great medicines. Science and patients are at the heart of everything we do.

We are a global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.

About our medicines

Science and patients are at the heart of everything we do, and our skills and resources are concentrated on those therapy areas where we believe we can make the most difference. We focus primarily on cancer, cardiovascular/metabolic disease and respiratory/inflammation/autoimmunity. Alongside this, we remain active in infection and neuroscience with targeted investments in opportunities and collaborations.

About our research and development

Our business strategy sets out our path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation.

Our Business Strategy

Alongside our own research and development, we continue to partner with others to access the best science and accelerate the delivery of new medicines. We have been active in building early stage biotech and academic alliances in recent years and we want to do more of these, alongside in-licensing and acquisitions to strengthen our pipeline and broaden the range of treatment options for physicians and patients.


More broadly, collaboration is part of everyday business for us. Understanding the needs of patients and healthcare professionals, and the perspectives of regulators and those who pay for healthcare, is critical to our continued success. We work closely with these groups to get the insights we need to deliver distinctive, targeted medicines that make a difference in healthcare.

Across all our activity, we are committed to driving business success responsibly, acting with integrity and working to high ethical standards to maintain the trust of our stakeholders.


Improving health is one of the toughest challenges facing the world today and it will take a sustained and significant effort to drive continued progress. AstraZeneca has a key contribution to make to that effort.

Fast facts

  • We operate in over 100 countries and our medicines are used by millions of patients worldwide
  • We employ around 50,000 people worldwide
  • We conduct R&D across 3 continents and we invest over $4 billion in R&D each year
  • We manufacture in 16 countries
  • Our sales in 2012 totalled $28 billion

Annual Report 2013

AstraZeneca Annual Report 2013

Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.